Clinical Trials Browser

Phase 2 × Has results × Peripheral Nervous System Diseases × Clear all

NCT02297412 2022-01-31

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Phase 2 Completed

47 enrolled 9 charts

Breast Neoplasms, Peripheral Nervous System Diseases, Acute Pain

NCT01783522 2019-10-22

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Phase 2 Terminated

9 enrolled 10 charts

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00952848 2017-03-29

Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy

Phase 2 Completed

18 enrolled 10 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

NCT00891618 2016-10-31

Acupuncture for Chemo-Induced Peripheral Neuropathy

Phase 2 Completed

27 enrolled 3 charts

LymphoidPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Peripheral Nervous System Diseases, Neoplasms, Plasma Cell

NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Phase 2 Completed

56 enrolled 5 charts

GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT00267007 2014-06-04

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Phase 2 Terminated

32 enrolled 9 charts

Neoplasms, Peripheral Nervous System Diseases